Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC26368131;8132;8133 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
N2AB26368131;8132;8133 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
N2A26368131;8132;8133 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
N2B25907993;7994;7995 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
Novex-125907993;7994;7995 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
Novex-225907993;7994;7995 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146
Novex-326368131;8132;8133 chr2:178771421;178771420;178771419chr2:179636148;179636147;179636146

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-16
  • Domain position: 16
  • Structural Position: 26
  • Q(SASA): 0.5568
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/V rs1207371966 0.189 0.01 N 0.228 0.335 0.417208245017 gnomAD-2.1.1 3.98E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.81E-06 0
E/V rs1207371966 0.189 0.01 N 0.228 0.335 0.417208245017 gnomAD-4.0.0 3.18187E-06 None None None None N None 0 0 None 0 0 None 0 0 5.715E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1279 likely_benign 0.1362 benign -0.847 Destabilizing 0.139 N 0.253 neutral N 0.445197897 None None N
E/C 0.8483 likely_pathogenic 0.8542 pathogenic -0.383 Destabilizing 0.995 D 0.322 neutral None None None None N
E/D 0.1686 likely_benign 0.1736 benign -0.762 Destabilizing 0.425 N 0.301 neutral N 0.431115871 None None N
E/F 0.7265 likely_pathogenic 0.7319 pathogenic -0.381 Destabilizing 0.944 D 0.378 neutral None None None None N
E/G 0.1741 likely_benign 0.1738 benign -1.145 Destabilizing 0.425 N 0.361 neutral N 0.504062077 None None N
E/H 0.493 ambiguous 0.4927 ambiguous -0.359 Destabilizing 0.944 D 0.369 neutral None None None None N
E/I 0.2911 likely_benign 0.3047 benign -0.053 Destabilizing 0.543 D 0.424 neutral None None None None N
E/K 0.1208 likely_benign 0.1216 benign -0.203 Destabilizing 0.27 N 0.296 neutral N 0.43158041 None None N
E/L 0.3064 likely_benign 0.3172 benign -0.053 Destabilizing 0.329 N 0.332 neutral None None None None N
E/M 0.3595 ambiguous 0.3716 ambiguous 0.24 Stabilizing 0.944 D 0.339 neutral None None None None N
E/N 0.2672 likely_benign 0.2809 benign -0.716 Destabilizing 0.704 D 0.289 neutral None None None None N
E/P 0.4379 ambiguous 0.4419 ambiguous -0.297 Destabilizing 0.828 D 0.416 neutral None None None None N
E/Q 0.1436 likely_benign 0.1452 benign -0.637 Destabilizing 0.023 N 0.163 neutral N 0.452411247 None None N
E/R 0.227 likely_benign 0.2198 benign 0.122 Stabilizing 0.007 N 0.17 neutral None None None None N
E/S 0.2077 likely_benign 0.2237 benign -0.948 Destabilizing 0.329 N 0.283 neutral None None None None N
E/T 0.1565 likely_benign 0.1651 benign -0.7 Destabilizing 0.004 N 0.183 neutral None None None None N
E/V 0.1615 likely_benign 0.167 benign -0.297 Destabilizing 0.01 N 0.228 neutral N 0.479132707 None None N
E/W 0.8843 likely_pathogenic 0.878 pathogenic -0.087 Destabilizing 0.995 D 0.335 neutral None None None None N
E/Y 0.6035 likely_pathogenic 0.5969 pathogenic -0.111 Destabilizing 0.981 D 0.407 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.